Upconverted Metal–Organic Framework Janus Architecture for Near-Infrared and Ultrasound Co-Enhanced High Performance Tumor Therapy

Zhao Wang,Bin Liu,Qianqian Sun,Lili Feng,Fei He,Piaoping Yang,Shili Gai,Zewei Quan,Jun Lin
DOI: https://doi.org/10.1021/acsnano.1c04280
IF: 17.1
2021-06-23
ACS Nano
Abstract:Strict conditions such as hypoxia, overexpression of glutathione (GSH), and high concentration of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) in the tumor microenvironment (TME) limit the therapeutic effects of reactive oxygen species (ROS) for photodynamic therapy (PDT), chemodynamic therapy (CDT), and sonodynamic therapy (SDT). Here we fabricated a biocatalytic Janus nanocomposite (denoted as UPFB) for ultrasound (US) driven SDT and 808 nm near-infrared (NIR) light mediated PDT by combining core–shell–shell upconversion nanoparticles (UCNPs, NaYF<sub>4</sub>:20%Yb,1%<sub>4</sub>:10%<sub>4</sub>) and a ferric zirconium porphyrin metal organic framework [PCN-224(Fe)]. Our design not only substantially overcomes the inefficient PDT effect arising from the inadequate Förster resonance energy transfer (FRET) process from UCNPs (donor) to MOFs (acceptor) with only NIR laser irradiation, but also promotes the ROS generation via GSH depletion and oxygen supply contributed by Fe<sup>3+</sup> ions coordinated in UPFB as a catalase-like nanozyme. Additionally, the converted Fe<sup>2+</sup> from the foregoing process can achieve CDT performance under acidic conditions, such as lysosomes. Meanwhile, UPFB linked with biotin exhibits a good targeting ability to rapidly accumulate in the tumor region, verified by fluorescence imaging and <i>T</i><sub>2</sub>-weighted magnetic resonance imaging (MRI). In a word, it is believed that the synthesis and antitumor detection of UPFB heterostructures render them suitable for application in cancer therapeutics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c04280?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c04280</a>.Figures S1–S16 and Table S1. Size distributions of UCNPs; TEM images of UPF at different magnifications; TEM images of the products when the UCNPs without PVP-coating; the stability of different concentrations of UPFB in the different physiological environment; C 1s and N 1s XPS spectra of UPFB; FT-IR spectra of different samples; TGA curves of different samples; Decay curves and fitted decay times of UCNPs and UPFB; UV–vis absorption spectra of free ICG (25 μM) and UPFB (200 μg mL<sup>–1</sup>); Michaelis–Menten kinetic analysis and Lineweaver–Burk plotting of UPFB in different conditions; UCL and CLSM images of UPFB; detection of GSH depletion <i>in vitro</i>; <i>T</i><sub>2</sub>-weighted MRI of UPFB <i>in vitro</i>; the eliminating rate curve of UPFB; the long-term toxicity assessment of UPFB <i>in vivo</i>; H&amp;E stained analysis of main organs; the <sup>1</sup>O<sub>2</sub> quantum yield calculations of different samples (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c04280/suppl_file/nn1c04280_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
What problem does this paper attempt to address?